Comments
Lupin Ltd on Tuesday said that its subsidiary Nanomi B.V. has completed the divestiture of the entire stake in Kyowa Pharmaceutical Industry Co Ltd to Unison Capital Partners IV, LPS and Unison Capital Partners IV (F). LP. The transaction generates post tax net cash inflow of approximately JPY 33,429 million (₹2,157.60 crore) and will significantly strengthen Lupin's consolidated balance sheet and overall financial position; net debt of the company will stand reduced to ₹1,075.30 crore from ₹4,361.80 crore.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.